nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—Microtubule Inhibition—Cabazitaxel—prostate cancer	0.479	0.707	CiPCiCtD
Griseofulvin—Microtubule Inhibition—Docetaxel—prostate cancer	0.199	0.293	CiPCiCtD
Griseofulvin—CYP3A4—prostate cancer	0.0856	1	CbGaD
Griseofulvin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0235	0.138	CbGbCtD
Griseofulvin—CYP1A2—Flutamide—prostate cancer	0.0195	0.115	CbGbCtD
Griseofulvin—CYP1A2—Estrone—prostate cancer	0.0141	0.0831	CbGbCtD
Griseofulvin—CYP3A4—Bicalutamide—prostate cancer	0.0123	0.0726	CbGbCtD
Griseofulvin—CYP3A4—Estramustine—prostate cancer	0.0115	0.0675	CbGbCtD
Griseofulvin—CYP3A4—Abiraterone—prostate cancer	0.0102	0.0602	CbGbCtD
Griseofulvin—CYP3A4—Flutamide—prostate cancer	0.0102	0.0602	CbGbCtD
Griseofulvin—CYP1A2—Conjugated Estrogens—prostate cancer	0.00922	0.0543	CbGbCtD
Griseofulvin—CYP1A2—Estradiol—prostate cancer	0.00809	0.0477	CbGbCtD
Griseofulvin—CYP3A4—Cabazitaxel—prostate cancer	0.00755	0.0445	CbGbCtD
Griseofulvin—CYP3A4—Estrone—prostate cancer	0.00738	0.0435	CbGbCtD
Griseofulvin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00658	0.0388	CbGbCtD
Griseofulvin—CYP1A2—Etoposide—prostate cancer	0.00528	0.0311	CbGbCtD
Griseofulvin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00483	0.0285	CbGbCtD
Griseofulvin—CYP3A4—Mitoxantrone—prostate cancer	0.00439	0.0259	CbGbCtD
Griseofulvin—CYP3A4—Estradiol—prostate cancer	0.00424	0.025	CbGbCtD
Griseofulvin—CYP3A4—Prednisone—prostate cancer	0.00365	0.0215	CbGbCtD
Griseofulvin—CYP3A4—Etoposide—prostate cancer	0.00277	0.0163	CbGbCtD
Griseofulvin—CYP3A4—Docetaxel—prostate cancer	0.00253	0.0149	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—prostate cancer	0.00189	0.0111	CbGbCtD
Griseofulvin—Neuropathy peripheral—Estradiol—prostate cancer	0.000146	0.00336	CcSEcCtD
Griseofulvin—Diarrhoea—Degarelix—prostate cancer	0.000146	0.00335	CcSEcCtD
Griseofulvin—Erythema—Conjugated Estrogens—prostate cancer	0.000145	0.00334	CcSEcCtD
Griseofulvin—Asthenia—Cabazitaxel—prostate cancer	0.000144	0.00331	CcSEcCtD
Griseofulvin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000142	0.00328	CcSEcCtD
Griseofulvin—Feeling abnormal—Bicalutamide—prostate cancer	0.000142	0.00326	CcSEcCtD
Griseofulvin—Nausea—Nilutamide—prostate cancer	0.000141	0.00326	CcSEcCtD
Griseofulvin—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000141	0.00325	CcSEcCtD
Griseofulvin—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000141	0.00325	CcSEcCtD
Griseofulvin—Nausea—Flutamide—prostate cancer	0.000141	0.00325	CcSEcCtD
Griseofulvin—Dizziness—Degarelix—prostate cancer	0.000141	0.00324	CcSEcCtD
Griseofulvin—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00014	0.00323	CcSEcCtD
Griseofulvin—Neuropathy—Prednisone—prostate cancer	0.000139	0.00319	CcSEcCtD
Griseofulvin—Diarrhoea—Cabazitaxel—prostate cancer	0.000137	0.00316	CcSEcCtD
Griseofulvin—Urticaria—Bicalutamide—prostate cancer	0.000137	0.00315	CcSEcCtD
Griseofulvin—Vomiting—Degarelix—prostate cancer	0.000135	0.00312	CcSEcCtD
Griseofulvin—Rash—Degarelix—prostate cancer	0.000134	0.00309	CcSEcCtD
Griseofulvin—Dermatitis—Degarelix—prostate cancer	0.000134	0.00309	CcSEcCtD
Griseofulvin—Hepatitis—Estradiol—prostate cancer	0.000133	0.00308	CcSEcCtD
Griseofulvin—Headache—Degarelix—prostate cancer	0.000133	0.00307	CcSEcCtD
Griseofulvin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000133	0.00306	CcSEcCtD
Griseofulvin—Angioedema—Conjugated Estrogens—prostate cancer	0.000133	0.00306	CcSEcCtD
Griseofulvin—Dizziness—Cabazitaxel—prostate cancer	0.000133	0.00305	CcSEcCtD
Griseofulvin—Leukopenia—Goserelin—prostate cancer	0.000131	0.00302	CcSEcCtD
Griseofulvin—Agranulocytosis—Mitoxantrone—prostate cancer	0.000129	0.00298	CcSEcCtD
Griseofulvin—Vomiting—Cabazitaxel—prostate cancer	0.000127	0.00294	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Epirubicin—prostate cancer	0.000127	0.00293	CcSEcCtD
Griseofulvin—Hypersensitivity—Bicalutamide—prostate cancer	0.000127	0.00292	CcSEcCtD
Griseofulvin—Nausea—Degarelix—prostate cancer	0.000126	0.00291	CcSEcCtD
Griseofulvin—Erythema multiforme—Estradiol—prostate cancer	0.000126	0.00291	CcSEcCtD
Griseofulvin—Headache—Cabazitaxel—prostate cancer	0.000126	0.00289	CcSEcCtD
Griseofulvin—Fatigue—Ethinyl Estradiol—prostate cancer	0.000125	0.00289	CcSEcCtD
Griseofulvin—Hepatitis—Mitoxantrone—prostate cancer	0.000124	0.00287	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	0.000124	0.00286	CcSEcCtD
Griseofulvin—Asthenia—Bicalutamide—prostate cancer	0.000123	0.00284	CcSEcCtD
Griseofulvin—Confusional state—Goserelin—prostate cancer	0.000121	0.00278	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	0.00012	0.00277	CcSEcCtD
Griseofulvin—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.00012	0.00276	CcSEcCtD
Griseofulvin—Nausea—Cabazitaxel—prostate cancer	0.000119	0.00274	CcSEcCtD
Griseofulvin—Diarrhoea—Bicalutamide—prostate cancer	0.000118	0.00271	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—prostate cancer	0.000117	0.00271	CcSEcCtD
Griseofulvin—Erythema—Estradiol—prostate cancer	0.000116	0.00268	CcSEcCtD
Griseofulvin—Urticaria—Ethinyl Estradiol—prostate cancer	0.000115	0.00266	CcSEcCtD
Griseofulvin—Dizziness—Bicalutamide—prostate cancer	0.000114	0.00262	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Etoposide—prostate cancer	0.000113	0.0026	CcSEcCtD
Griseofulvin—Candida infection—Epirubicin—prostate cancer	0.00011	0.00254	CcSEcCtD
Griseofulvin—Vomiting—Bicalutamide—prostate cancer	0.000109	0.00252	CcSEcCtD
Griseofulvin—Rash—Bicalutamide—prostate cancer	0.000108	0.0025	CcSEcCtD
Griseofulvin—Neuropathy—Epirubicin—prostate cancer	0.000108	0.0025	CcSEcCtD
Griseofulvin—Dermatitis—Bicalutamide—prostate cancer	0.000108	0.0025	CcSEcCtD
Griseofulvin—Erythema—Mitoxantrone—prostate cancer	0.000108	0.00249	CcSEcCtD
Griseofulvin—Insomnia—Goserelin—prostate cancer	0.000108	0.00249	CcSEcCtD
Griseofulvin—Headache—Bicalutamide—prostate cancer	0.000108	0.00248	CcSEcCtD
Griseofulvin—Agranulocytosis—Etoposide—prostate cancer	0.000108	0.00248	CcSEcCtD
Griseofulvin—Paraesthesia—Goserelin—prostate cancer	0.000107	0.00247	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000107	0.00247	CcSEcCtD
Griseofulvin—Insomnia—Conjugated Estrogens—prostate cancer	0.000107	0.00247	CcSEcCtD
Griseofulvin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000107	0.00247	CcSEcCtD
Griseofulvin—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000106	0.00245	CcSEcCtD
Griseofulvin—Angioedema—Estradiol—prostate cancer	0.000106	0.00245	CcSEcCtD
Griseofulvin—Dyspepsia—Goserelin—prostate cancer	0.000105	0.00243	CcSEcCtD
Griseofulvin—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000104	0.0024	CcSEcCtD
Griseofulvin—Asthenia—Ethinyl Estradiol—prostate cancer	0.000104	0.0024	CcSEcCtD
Griseofulvin—Fatigue—Goserelin—prostate cancer	0.000103	0.00238	CcSEcCtD
Griseofulvin—Fatigue—Conjugated Estrogens—prostate cancer	0.000102	0.00235	CcSEcCtD
Griseofulvin—Nausea—Bicalutamide—prostate cancer	0.000102	0.00235	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—prostate cancer	0.000102	0.00235	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—prostate cancer	0.0001	0.00231	CcSEcCtD
Griseofulvin—Diarrhoea—Ethinyl Estradiol—prostate cancer	9.94e-05	0.00229	CcSEcCtD
Griseofulvin—Feeling abnormal—Goserelin—prostate cancer	9.86e-05	0.00227	CcSEcCtD
Griseofulvin—Erythema multiforme—Etoposide—prostate cancer	9.78e-05	0.00225	CcSEcCtD
Griseofulvin—Leukopenia—Mitoxantrone—prostate cancer	9.69e-05	0.00223	CcSEcCtD
Griseofulvin—Dizziness—Ethinyl Estradiol—prostate cancer	9.61e-05	0.00221	CcSEcCtD
Griseofulvin—Confusional state—Estradiol—prostate cancer	9.56e-05	0.0022	CcSEcCtD
Griseofulvin—Urticaria—Goserelin—prostate cancer	9.5e-05	0.00219	CcSEcCtD
Griseofulvin—Urticaria—Conjugated Estrogens—prostate cancer	9.41e-05	0.00217	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Docetaxel—prostate cancer	9.39e-05	0.00216	CcSEcCtD
Griseofulvin—Vomiting—Ethinyl Estradiol—prostate cancer	9.24e-05	0.00213	CcSEcCtD
Griseofulvin—Rash—Ethinyl Estradiol—prostate cancer	9.16e-05	0.00211	CcSEcCtD
Griseofulvin—Dermatitis—Ethinyl Estradiol—prostate cancer	9.16e-05	0.00211	CcSEcCtD
Griseofulvin—Headache—Ethinyl Estradiol—prostate cancer	9.11e-05	0.0021	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Capecitabine—prostate cancer	9.09e-05	0.00209	CcSEcCtD
Griseofulvin—Agranulocytosis—Docetaxel—prostate cancer	8.94e-05	0.00206	CcSEcCtD
Griseofulvin—Confusional state—Mitoxantrone—prostate cancer	8.91e-05	0.00205	CcSEcCtD
Griseofulvin—Hypersensitivity—Goserelin—prostate cancer	8.81e-05	0.00203	CcSEcCtD
Griseofulvin—Hypersensitivity—Conjugated Estrogens—prostate cancer	8.73e-05	0.00201	CcSEcCtD
Griseofulvin—Agranulocytosis—Capecitabine—prostate cancer	8.65e-05	0.00199	CcSEcCtD
Griseofulvin—Nausea—Ethinyl Estradiol—prostate cancer	8.63e-05	0.00199	CcSEcCtD
Griseofulvin—Hepatitis—Docetaxel—prostate cancer	8.6e-05	0.00198	CcSEcCtD
Griseofulvin—Asthenia—Goserelin—prostate cancer	8.58e-05	0.00198	CcSEcCtD
Griseofulvin—Insomnia—Estradiol—prostate cancer	8.58e-05	0.00198	CcSEcCtD
Griseofulvin—Paraesthesia—Estradiol—prostate cancer	8.52e-05	0.00196	CcSEcCtD
Griseofulvin—Asthenia—Conjugated Estrogens—prostate cancer	8.5e-05	0.00196	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	8.38e-05	0.00193	CcSEcCtD
Griseofulvin—Dyspepsia—Estradiol—prostate cancer	8.35e-05	0.00192	CcSEcCtD
Griseofulvin—Hepatitis—Capecitabine—prostate cancer	8.32e-05	0.00192	CcSEcCtD
Griseofulvin—Diarrhoea—Goserelin—prostate cancer	8.18e-05	0.00189	CcSEcCtD
Griseofulvin—Fatigue—Estradiol—prostate cancer	8.18e-05	0.00188	CcSEcCtD
Griseofulvin—Erythema multiforme—Docetaxel—prostate cancer	8.13e-05	0.00187	CcSEcCtD
Griseofulvin—Diarrhoea—Conjugated Estrogens—prostate cancer	8.11e-05	0.00187	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Prednisone—prostate cancer	8.1e-05	0.00187	CcSEcCtD
Griseofulvin—Leukopenia—Etoposide—prostate cancer	8.06e-05	0.00186	CcSEcCtD
Griseofulvin—Paraesthesia—Mitoxantrone—prostate cancer	7.93e-05	0.00183	CcSEcCtD
Griseofulvin—Dizziness—Goserelin—prostate cancer	7.91e-05	0.00182	CcSEcCtD
Griseofulvin—Erythema multiforme—Capecitabine—prostate cancer	7.87e-05	0.00181	CcSEcCtD
Griseofulvin—Dizziness—Conjugated Estrogens—prostate cancer	7.84e-05	0.00181	CcSEcCtD
Griseofulvin—Feeling abnormal—Estradiol—prostate cancer	7.81e-05	0.0018	CcSEcCtD
Griseofulvin—Dyspepsia—Mitoxantrone—prostate cancer	7.78e-05	0.00179	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	7.76e-05	0.00179	CcSEcCtD
Griseofulvin—Fatigue—Mitoxantrone—prostate cancer	7.62e-05	0.00176	CcSEcCtD
Griseofulvin—Vomiting—Goserelin—prostate cancer	7.61e-05	0.00175	CcSEcCtD
Griseofulvin—Rash—Goserelin—prostate cancer	7.54e-05	0.00174	CcSEcCtD
Griseofulvin—Dermatitis—Goserelin—prostate cancer	7.54e-05	0.00174	CcSEcCtD
Griseofulvin—Vomiting—Conjugated Estrogens—prostate cancer	7.53e-05	0.00174	CcSEcCtD
Griseofulvin—Urticaria—Estradiol—prostate cancer	7.53e-05	0.00174	CcSEcCtD
Griseofulvin—Headache—Goserelin—prostate cancer	7.49e-05	0.00173	CcSEcCtD
Griseofulvin—Erythema—Docetaxel—prostate cancer	7.48e-05	0.00172	CcSEcCtD
Griseofulvin—Rash—Conjugated Estrogens—prostate cancer	7.47e-05	0.00172	CcSEcCtD
Griseofulvin—Dermatitis—Conjugated Estrogens—prostate cancer	7.46e-05	0.00172	CcSEcCtD
Griseofulvin—Headache—Conjugated Estrogens—prostate cancer	7.42e-05	0.00171	CcSEcCtD
Griseofulvin—Confusional state—Etoposide—prostate cancer	7.41e-05	0.00171	CcSEcCtD
Griseofulvin—Feeling abnormal—Mitoxantrone—prostate cancer	7.28e-05	0.00168	CcSEcCtD
Griseofulvin—Erythema—Capecitabine—prostate cancer	7.25e-05	0.00167	CcSEcCtD
Griseofulvin—Nausea—Goserelin—prostate cancer	7.11e-05	0.00164	CcSEcCtD
Griseofulvin—Nausea—Conjugated Estrogens—prostate cancer	7.04e-05	0.00162	CcSEcCtD
Griseofulvin—Urticaria—Mitoxantrone—prostate cancer	7.02e-05	0.00162	CcSEcCtD
Griseofulvin—Hypersensitivity—Estradiol—prostate cancer	6.99e-05	0.00161	CcSEcCtD
Griseofulvin—Asthenia—Estradiol—prostate cancer	6.8e-05	0.00157	CcSEcCtD
Griseofulvin—Leukopenia—Docetaxel—prostate cancer	6.7e-05	0.00154	CcSEcCtD
Griseofulvin—Paraesthesia—Etoposide—prostate cancer	6.6e-05	0.00152	CcSEcCtD
Griseofulvin—Hypersensitivity—Mitoxantrone—prostate cancer	6.51e-05	0.0015	CcSEcCtD
Griseofulvin—Diarrhoea—Estradiol—prostate cancer	6.49e-05	0.00149	CcSEcCtD
Griseofulvin—Leukopenia—Capecitabine—prostate cancer	6.49e-05	0.00149	CcSEcCtD
Griseofulvin—Erythema—Prednisone—prostate cancer	6.45e-05	0.00149	CcSEcCtD
Griseofulvin—Asthenia—Mitoxantrone—prostate cancer	6.34e-05	0.00146	CcSEcCtD
Griseofulvin—Fatigue—Etoposide—prostate cancer	6.34e-05	0.00146	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Epirubicin—prostate cancer	6.33e-05	0.00146	CcSEcCtD
Griseofulvin—Dizziness—Estradiol—prostate cancer	6.27e-05	0.00144	CcSEcCtD
Griseofulvin—Confusional state—Docetaxel—prostate cancer	6.16e-05	0.00142	CcSEcCtD
Griseofulvin—Feeling abnormal—Etoposide—prostate cancer	6.06e-05	0.0014	CcSEcCtD
Griseofulvin—Diarrhoea—Mitoxantrone—prostate cancer	6.05e-05	0.00139	CcSEcCtD
Griseofulvin—Vomiting—Estradiol—prostate cancer	6.03e-05	0.00139	CcSEcCtD
Griseofulvin—Agranulocytosis—Epirubicin—prostate cancer	6.03e-05	0.00139	CcSEcCtD
Griseofulvin—Rash—Estradiol—prostate cancer	5.98e-05	0.00138	CcSEcCtD
Griseofulvin—Dermatitis—Estradiol—prostate cancer	5.97e-05	0.00138	CcSEcCtD
Griseofulvin—Confusional state—Capecitabine—prostate cancer	5.96e-05	0.00137	CcSEcCtD
Griseofulvin—Headache—Estradiol—prostate cancer	5.94e-05	0.00137	CcSEcCtD
Griseofulvin—Angioedema—Prednisone—prostate cancer	5.9e-05	0.00136	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—prostate cancer	5.86e-05	0.00135	CcSEcCtD
Griseofulvin—Urticaria—Etoposide—prostate cancer	5.84e-05	0.00135	CcSEcCtD
Griseofulvin—Hepatitis—Epirubicin—prostate cancer	5.8e-05	0.00134	CcSEcCtD
Griseofulvin—Nausea—Estradiol—prostate cancer	5.63e-05	0.0013	CcSEcCtD
Griseofulvin—Vomiting—Mitoxantrone—prostate cancer	5.62e-05	0.00129	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—prostate cancer	5.58e-05	0.00129	CcSEcCtD
Griseofulvin—Rash—Mitoxantrone—prostate cancer	5.57e-05	0.00128	CcSEcCtD
Griseofulvin—Dermatitis—Mitoxantrone—prostate cancer	5.57e-05	0.00128	CcSEcCtD
Griseofulvin—Headache—Mitoxantrone—prostate cancer	5.54e-05	0.00128	CcSEcCtD
Griseofulvin—Insomnia—Docetaxel—prostate cancer	5.52e-05	0.00127	CcSEcCtD
Griseofulvin—Paraesthesia—Docetaxel—prostate cancer	5.48e-05	0.00126	CcSEcCtD
Griseofulvin—Erythema multiforme—Epirubicin—prostate cancer	5.48e-05	0.00126	CcSEcCtD
Griseofulvin—Hypersensitivity—Etoposide—prostate cancer	5.41e-05	0.00125	CcSEcCtD
Griseofulvin—Dyspepsia—Docetaxel—prostate cancer	5.38e-05	0.00124	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—prostate cancer	5.37e-05	0.00124	CcSEcCtD
Griseofulvin—Insomnia—Capecitabine—prostate cancer	5.35e-05	0.00123	CcSEcCtD
Griseofulvin—Paraesthesia—Capecitabine—prostate cancer	5.31e-05	0.00122	CcSEcCtD
Griseofulvin—Asthenia—Etoposide—prostate cancer	5.27e-05	0.00121	CcSEcCtD
Griseofulvin—Fatigue—Docetaxel—prostate cancer	5.27e-05	0.00121	CcSEcCtD
Griseofulvin—Nausea—Mitoxantrone—prostate cancer	5.25e-05	0.00121	CcSEcCtD
Griseofulvin—Dyspepsia—Capecitabine—prostate cancer	5.21e-05	0.0012	CcSEcCtD
Griseofulvin—Fatigue—Capecitabine—prostate cancer	5.1e-05	0.00117	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—prostate cancer	5.07e-05	0.00117	CcSEcCtD
Griseofulvin—Erythema—Epirubicin—prostate cancer	5.05e-05	0.00116	CcSEcCtD
Griseofulvin—Feeling abnormal—Docetaxel—prostate cancer	5.03e-05	0.00116	CcSEcCtD
Griseofulvin—Diarrhoea—Etoposide—prostate cancer	5.03e-05	0.00116	CcSEcCtD
Griseofulvin—Feeling abnormal—Capecitabine—prostate cancer	4.87e-05	0.00112	CcSEcCtD
Griseofulvin—Dizziness—Etoposide—prostate cancer	4.86e-05	0.00112	CcSEcCtD
Griseofulvin—Insomnia—Prednisone—prostate cancer	4.76e-05	0.0011	CcSEcCtD
Griseofulvin—Paraesthesia—Prednisone—prostate cancer	4.73e-05	0.00109	CcSEcCtD
Griseofulvin—Urticaria—Capecitabine—prostate cancer	4.7e-05	0.00108	CcSEcCtD
Griseofulvin—Vomiting—Etoposide—prostate cancer	4.67e-05	0.00108	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—prostate cancer	4.67e-05	0.00108	CcSEcCtD
Griseofulvin—Dyspepsia—Prednisone—prostate cancer	4.64e-05	0.00107	CcSEcCtD
Griseofulvin—Rash—Etoposide—prostate cancer	4.63e-05	0.00107	CcSEcCtD
Griseofulvin—Dermatitis—Etoposide—prostate cancer	4.63e-05	0.00107	CcSEcCtD
Griseofulvin—Headache—Etoposide—prostate cancer	4.6e-05	0.00106	CcSEcCtD
Griseofulvin—Fatigue—Prednisone—prostate cancer	4.54e-05	0.00105	CcSEcCtD
Griseofulvin—Leukopenia—Epirubicin—prostate cancer	4.52e-05	0.00104	CcSEcCtD
Griseofulvin—Hypersensitivity—Docetaxel—prostate cancer	4.5e-05	0.00104	CcSEcCtD
Griseofulvin—Asthenia—Docetaxel—prostate cancer	4.38e-05	0.00101	CcSEcCtD
Griseofulvin—Nausea—Etoposide—prostate cancer	4.37e-05	0.00101	CcSEcCtD
Griseofulvin—Hypersensitivity—Capecitabine—prostate cancer	4.36e-05	0.001	CcSEcCtD
Griseofulvin—Feeling abnormal—Prednisone—prostate cancer	4.34e-05	0.001	CcSEcCtD
Griseofulvin—Asthenia—Capecitabine—prostate cancer	4.24e-05	0.000978	CcSEcCtD
Griseofulvin—Urticaria—Prednisone—prostate cancer	4.18e-05	0.000964	CcSEcCtD
Griseofulvin—Leukopenia—Doxorubicin—prostate cancer	4.18e-05	0.000963	CcSEcCtD
Griseofulvin—Diarrhoea—Docetaxel—prostate cancer	4.18e-05	0.000963	CcSEcCtD
Griseofulvin—Confusional state—Epirubicin—prostate cancer	4.15e-05	0.000957	CcSEcCtD
Griseofulvin—Diarrhoea—Capecitabine—prostate cancer	4.05e-05	0.000932	CcSEcCtD
Griseofulvin—Dizziness—Docetaxel—prostate cancer	4.04e-05	0.000931	CcSEcCtD
Griseofulvin—Dizziness—Capecitabine—prostate cancer	3.91e-05	0.000901	CcSEcCtD
Griseofulvin—Vomiting—Docetaxel—prostate cancer	3.88e-05	0.000895	CcSEcCtD
Griseofulvin—Hypersensitivity—Prednisone—prostate cancer	3.88e-05	0.000894	CcSEcCtD
Griseofulvin—Rash—Docetaxel—prostate cancer	3.85e-05	0.000887	CcSEcCtD
Griseofulvin—Dermatitis—Docetaxel—prostate cancer	3.85e-05	0.000886	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—prostate cancer	3.84e-05	0.000886	CcSEcCtD
Griseofulvin—Headache—Docetaxel—prostate cancer	3.83e-05	0.000882	CcSEcCtD
Griseofulvin—Asthenia—Prednisone—prostate cancer	3.78e-05	0.000871	CcSEcCtD
Griseofulvin—Vomiting—Capecitabine—prostate cancer	3.76e-05	0.000866	CcSEcCtD
Griseofulvin—Rash—Capecitabine—prostate cancer	3.73e-05	0.000859	CcSEcCtD
Griseofulvin—Insomnia—Epirubicin—prostate cancer	3.73e-05	0.000858	CcSEcCtD
Griseofulvin—Dermatitis—Capecitabine—prostate cancer	3.73e-05	0.000858	CcSEcCtD
Griseofulvin—Headache—Capecitabine—prostate cancer	3.7e-05	0.000854	CcSEcCtD
Griseofulvin—Paraesthesia—Epirubicin—prostate cancer	3.7e-05	0.000852	CcSEcCtD
Griseofulvin—Nausea—Docetaxel—prostate cancer	3.63e-05	0.000836	CcSEcCtD
Griseofulvin—Dyspepsia—Epirubicin—prostate cancer	3.63e-05	0.000835	CcSEcCtD
Griseofulvin—Diarrhoea—Prednisone—prostate cancer	3.6e-05	0.00083	CcSEcCtD
Griseofulvin—Fatigue—Epirubicin—prostate cancer	3.55e-05	0.000818	CcSEcCtD
Griseofulvin—Nausea—Capecitabine—prostate cancer	3.51e-05	0.000809	CcSEcCtD
Griseofulvin—Dizziness—Prednisone—prostate cancer	3.48e-05	0.000803	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—prostate cancer	3.45e-05	0.000794	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—prostate cancer	3.42e-05	0.000789	CcSEcCtD
Griseofulvin—Feeling abnormal—Epirubicin—prostate cancer	3.39e-05	0.000782	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—prostate cancer	3.36e-05	0.000773	CcSEcCtD
Griseofulvin—Vomiting—Prednisone—prostate cancer	3.35e-05	0.000772	CcSEcCtD
Griseofulvin—Rash—Prednisone—prostate cancer	3.32e-05	0.000765	CcSEcCtD
Griseofulvin—Dermatitis—Prednisone—prostate cancer	3.32e-05	0.000764	CcSEcCtD
Griseofulvin—Headache—Prednisone—prostate cancer	3.3e-05	0.00076	CcSEcCtD
Griseofulvin—Fatigue—Doxorubicin—prostate cancer	3.29e-05	0.000757	CcSEcCtD
Griseofulvin—Urticaria—Epirubicin—prostate cancer	3.27e-05	0.000754	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—prostate cancer	3.14e-05	0.000724	CcSEcCtD
Griseofulvin—Nausea—Prednisone—prostate cancer	3.13e-05	0.000721	CcSEcCtD
Griseofulvin—Hypersensitivity—Epirubicin—prostate cancer	3.04e-05	0.000699	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—prostate cancer	3.03e-05	0.000698	CcSEcCtD
Griseofulvin—Asthenia—Epirubicin—prostate cancer	2.96e-05	0.000681	CcSEcCtD
Griseofulvin—Diarrhoea—Epirubicin—prostate cancer	2.82e-05	0.000649	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—prostate cancer	2.81e-05	0.000647	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—prostate cancer	2.74e-05	0.00063	CcSEcCtD
Griseofulvin—Dizziness—Epirubicin—prostate cancer	2.72e-05	0.000628	CcSEcCtD
Griseofulvin—Vomiting—Epirubicin—prostate cancer	2.62e-05	0.000603	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—prostate cancer	2.61e-05	0.000601	CcSEcCtD
Griseofulvin—Rash—Epirubicin—prostate cancer	2.6e-05	0.000598	CcSEcCtD
Griseofulvin—Dermatitis—Epirubicin—prostate cancer	2.6e-05	0.000598	CcSEcCtD
Griseofulvin—Headache—Epirubicin—prostate cancer	2.58e-05	0.000595	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—prostate cancer	2.52e-05	0.000581	CcSEcCtD
Griseofulvin—Nausea—Epirubicin—prostate cancer	2.45e-05	0.000564	CcSEcCtD
Griseofulvin—Vomiting—Doxorubicin—prostate cancer	2.42e-05	0.000558	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—prostate cancer	2.4e-05	0.000554	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—prostate cancer	2.4e-05	0.000553	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—prostate cancer	2.39e-05	0.00055	CcSEcCtD
Griseofulvin—Nausea—Doxorubicin—prostate cancer	2.26e-05	0.000522	CcSEcCtD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	1.03e-05	0.000426	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.01e-05	0.00042	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	9.96e-06	0.000414	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	9.83e-06	0.000408	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—RXRA—prostate cancer	9.62e-06	0.000399	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	9.58e-06	0.000398	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—COMT—prostate cancer	9.26e-06	0.000385	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTP1—prostate cancer	9.22e-06	0.000383	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	9.18e-06	0.000381	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	9.14e-06	0.000379	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	9.09e-06	0.000378	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	8.84e-06	0.000367	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	8.54e-06	0.000354	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTM1—prostate cancer	8.47e-06	0.000352	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CSAD—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CBR1—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GRHL1—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PSAT1—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TST—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ADI1—prostate cancer	8.37e-06	0.000348	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	8.36e-06	0.000347	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	8.18e-06	0.00034	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	8.03e-06	0.000334	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	8.03e-06	0.000333	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HAO1—prostate cancer	7.93e-06	0.000329	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	7.92e-06	0.000329	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GRHPR—prostate cancer	7.78e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CKMT2—prostate cancer	7.78e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UGT2B17—prostate cancer	7.78e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UGT2B15—prostate cancer	7.78e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	7.61e-06	0.000316	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	7.48e-06	0.000311	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM3—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MBTPS1—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—RFK—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAGLU—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PGAM2—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SULT2B1—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AOX1—prostate cancer	7.32e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	7.15e-06	0.000297	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP3A43—prostate cancer	6.94e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AMACR—prostate cancer	6.94e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SRD5A2—prostate cancer	6.94e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—DEGS1—prostate cancer	6.94e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAT1—prostate cancer	6.94e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	6.82e-06	0.000283	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	6.78e-06	0.000282	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HSD17B1—prostate cancer	6.62e-06	0.000275	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	6.62e-06	0.000275	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ADI1—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CBR1—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GRHL1—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CSAD—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TST—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PSAT1—prostate cancer	6.46e-06	0.000268	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	6.36e-06	0.000264	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	6.33e-06	0.000263	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.27e-06	0.00026	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UGT2B17—prostate cancer	6.01e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CKMT2—prostate cancer	6.01e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GRHPR—prostate cancer	6.01e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UGT2B15—prostate cancer	6.01e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	5.97e-06	0.000248	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—B4GALT4—prostate cancer	5.9e-06	0.000245	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HPGD—prostate cancer	5.9e-06	0.000245	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SULT2B1—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAGLU—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM3—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—RFK—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MBTPS1—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PGAM2—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AOX1—prostate cancer	5.65e-06	0.000235	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TNFRSF21—prostate cancer	5.55e-06	0.00023	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MTAP—prostate cancer	5.4e-06	0.000224	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP7B1—prostate cancer	5.4e-06	0.000224	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP3A43—prostate cancer	5.35e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AMACR—prostate cancer	5.35e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAT1—prostate cancer	5.35e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SRD5A2—prostate cancer	5.35e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—DEGS1—prostate cancer	5.35e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.27e-06	0.000219	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SULT1E1—prostate cancer	5.26e-06	0.000218	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SRD5A1—prostate cancer	5.26e-06	0.000218	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HSD17B1—prostate cancer	5.11e-06	0.000212	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.11e-06	0.000212	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.03e-06	0.000209	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HSD17B3—prostate cancer	5.02e-06	0.000208	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ACSL4—prostate cancer	5.02e-06	0.000208	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.96e-06	0.000206	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ARG2—prostate cancer	4.81e-06	0.0002	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PHGDH—prostate cancer	4.81e-06	0.0002	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UMPS—prostate cancer	4.81e-06	0.0002	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.79e-06	0.000199	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—LDHB—prostate cancer	4.72e-06	0.000196	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP3A5—prostate cancer	4.63e-06	0.000192	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.55e-06	0.000189	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HPGD—prostate cancer	4.55e-06	0.000189	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PDHA1—prostate cancer	4.47e-06	0.000186	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA3—prostate cancer	4.47e-06	0.000186	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UCP3—prostate cancer	4.47e-06	0.000186	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TCN2—prostate cancer	4.47e-06	0.000186	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.28e-06	0.000178	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SLC22A3—prostate cancer	4.27e-06	0.000177	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HSD3B1—prostate cancer	4.27e-06	0.000177	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.16e-06	0.000173	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MTAP—prostate cancer	4.16e-06	0.000173	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.14e-06	0.000172	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TBXAS1—prostate cancer	4.09e-06	0.00017	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA4—prostate cancer	4.09e-06	0.00017	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.06e-06	0.000168	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.06e-06	0.000168	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4e-06	0.000166	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA2—prostate cancer	3.98e-06	0.000165	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SULT1A1—prostate cancer	3.94e-06	0.000163	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ABCG5—prostate cancer	3.94e-06	0.000163	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.87e-06	0.000161	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ACSL4—prostate cancer	3.87e-06	0.000161	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA1—prostate cancer	3.84e-06	0.00016	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAT2—prostate cancer	3.8e-06	0.000158	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HSD3B2—prostate cancer	3.8e-06	0.000158	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTO1—prostate cancer	3.8e-06	0.000158	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UMPS—prostate cancer	3.71e-06	0.000154	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PHGDH—prostate cancer	3.71e-06	0.000154	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ARG2—prostate cancer	3.71e-06	0.000154	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.66e-06	0.000152	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2C18—prostate cancer	3.64e-06	0.000151	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PLCB2—prostate cancer	3.64e-06	0.000151	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—LRP2—prostate cancer	3.64e-06	0.000151	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—LDHB—prostate cancer	3.64e-06	0.000151	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—P4HB—prostate cancer	3.57e-06	0.000148	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.57e-06	0.000148	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.48e-06	0.000144	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PDHA1—prostate cancer	3.45e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UCP3—prostate cancer	3.45e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA3—prostate cancer	3.45e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TCN2—prostate cancer	3.45e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.44e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.39e-06	0.000141	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MED12—prostate cancer	3.33e-06	0.000138	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GNG5—prostate cancer	3.31e-06	0.000137	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.29e-06	0.000137	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.29e-06	0.000137	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NCOA3—prostate cancer	3.19e-06	0.000132	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA4—prostate cancer	3.16e-06	0.000131	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.16e-06	0.000131	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.13e-06	0.00013	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA2—prostate cancer	3.08e-06	0.000128	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HPGDS—prostate cancer	3.04e-06	0.000126	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.04e-06	0.000126	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ABCG5—prostate cancer	3.04e-06	0.000126	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.02e-06	0.000125	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA1—prostate cancer	2.97e-06	0.000123	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTT1—prostate cancer	2.95e-06	0.000122	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ACHE—prostate cancer	2.95e-06	0.000122	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTO1—prostate cancer	2.93e-06	0.000122	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.93e-06	0.000122	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAT2—prostate cancer	2.93e-06	0.000122	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.91e-06	0.000121	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.9e-06	0.000121	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.83e-06	0.000118	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PRKACB—prostate cancer	2.82e-06	0.000117	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—LRP2—prostate cancer	2.81e-06	0.000117	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PLCB2—prostate cancer	2.81e-06	0.000117	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.81e-06	0.000117	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.79e-06	0.000116	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—P4HB—prostate cancer	2.76e-06	0.000115	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.75e-06	0.000114	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.68e-06	0.000111	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NCOA2—prostate cancer	2.66e-06	0.00011	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.61e-06	0.000109	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MED12—prostate cancer	2.57e-06	0.000107	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GNG5—prostate cancer	2.55e-06	0.000106	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.54e-06	0.000105	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.48e-06	0.000103	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NCOA3—prostate cancer	2.46e-06	0.000102	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NQO1—prostate cancer	2.45e-06	0.000102	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TH—prostate cancer	2.41e-06	0.0001	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.4e-06	9.96e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.39e-06	9.92e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.38e-06	9.87e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.35e-06	9.75e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HPGDS—prostate cancer	2.35e-06	9.74e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.33e-06	9.68e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ACHE—prostate cancer	2.27e-06	9.45e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTT1—prostate cancer	2.27e-06	9.45e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GGT1—prostate cancer	2.27e-06	9.44e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.25e-06	9.34e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NCOA1—prostate cancer	2.24e-06	9.3e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.21e-06	9.17e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.19e-06	9.08e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PRKACB—prostate cancer	2.18e-06	9.03e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.15e-06	8.94e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—RXRA—prostate cancer	2.13e-06	8.85e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.07e-06	8.61e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—COMT—prostate cancer	2.05e-06	8.52e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NCOA2—prostate cancer	2.05e-06	8.52e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTP1—prostate cancer	2.04e-06	8.48e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ITPR1—prostate cancer	2.01e-06	8.35e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.98e-06	8.21e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.96e-06	8.13e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.91e-06	7.94e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TYMS—prostate cancer	1.9e-06	7.89e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NQO1—prostate cancer	1.89e-06	7.85e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM1—prostate cancer	1.88e-06	7.8e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TH—prostate cancer	1.86e-06	7.74e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—LPL—prostate cancer	1.84e-06	7.65e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.81e-06	7.53e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.78e-06	7.39e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ERCC2—prostate cancer	1.77e-06	7.33e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GGT1—prostate cancer	1.76e-06	7.29e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NCOA1—prostate cancer	1.73e-06	7.18e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.7e-06	7.08e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MTHFR—prostate cancer	1.66e-06	6.89e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—RXRA—prostate cancer	1.64e-06	6.83e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PPARA—prostate cancer	1.63e-06	6.76e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—COMT—prostate cancer	1.58e-06	6.58e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTP1—prostate cancer	1.58e-06	6.55e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ITPR1—prostate cancer	1.55e-06	6.44e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CAV1—prostate cancer	1.53e-06	6.35e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TYMS—prostate cancer	1.47e-06	6.09e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.46e-06	6.07e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.45e-06	6.02e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—LPL—prostate cancer	1.42e-06	5.91e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.39e-06	5.79e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.37e-06	5.7e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.36e-06	5.66e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—INS—prostate cancer	1.32e-06	5.48e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CREBBP—prostate cancer	1.29e-06	5.37e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.28e-06	5.32e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PPARA—prostate cancer	1.26e-06	5.22e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.23e-06	5.09e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CAV1—prostate cancer	1.18e-06	4.9e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NOS3—prostate cancer	1.16e-06	4.81e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.08e-06	4.47e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.07e-06	4.44e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTGS2—prostate cancer	1.06e-06	4.39e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—INS—prostate cancer	1.02e-06	4.23e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CREBBP—prostate cancer	9.98e-07	4.14e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.46e-07	3.93e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTEN—prostate cancer	9.23e-07	3.83e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NOS3—prostate cancer	8.93e-07	3.71e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—EP300—prostate cancer	8.8e-07	3.66e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.24e-07	3.42e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTGS2—prostate cancer	8.17e-07	3.39e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTEN—prostate cancer	7.12e-07	2.96e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—EP300—prostate cancer	6.79e-07	2.82e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.51e-07	2.7e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AKT1—prostate cancer	5.32e-07	2.21e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.03e-07	2.09e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AKT1—prostate cancer	4.11e-07	1.7e-05	CbGpPWpGaD
